Akorn Recalls Eptifibatide Injection Vials Due to Fill Volume and Impurity Issues
Akorn, Inc. is recalling 648 vials of Eptifibatide Injection because the fill volume was below specification and a known impurity exceeded limits.
- Product
- Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.
- Category
- Drug
- Distribution
- Distributed nationwide